Year: 2026
Type: preprint
Abstract: Biological staging models are a key tool for assessing the severity of Alzheimer's disease (AD), supporting personalized medicine and playing a critical role in clinical trial design. Recently, researchers have leveraged positron emission tomography (PET) to inform data-driven staging models of brain pathology related to AD. However, most approaches have focused on staging either amyloid or tau progressions separately, while both pathologies constitute defining factors of AD. Here, we aimed to derive a data-driven staging model which encompasses the spatial spread of both amyloid and tau. We assembled a large sample (n=3,293) of individuals with both amyloid and tau PET imaging stemming from 8 neuroimaging studies of AD and aging. We applied unsupervised machine learning to estimate brain areas which showed coordinated pathological accumulation across our sample, and we used these regions to inform a data-driven model for staging amyloid and tau. The resulting six stage model showed two stages of amyloid progression followed by four stages of tau spread, which were associated with cross-sectional and longitudinal assessments of cognitive decline. Comparison of our biological staging model with clinical disease stages recommended by the Alzheimer's Association showed evidence of heterogenous symptom profiles. Replication of results in holdout data demonstrated the generalizability and prognostic value of our staging model. Together, these findings establish a comprehensive and rigorously validated biological staging model that jointly characterizes amyloid and tau progression, advances beyond global or anatomically predefined summaries, and provides a scalable framework for studying disease heterogeneity and progression in AD.
Source: medRxiv
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: Role of age, dopamine, and tau related network disruption in setting a context for progression toward Alzheimer's disease, Michigan Alzheimer's Disease Core Center, UC Davis Alzheimer's Disease Core Center, Modeling Axonal Density and Inflammation-Associated Cellularity in Alzheimer’s Disease Using Hybrid Diffusion Imaging, Indiana Alzheimer Disease Center, Alzheimer's Disease Research Center, Mapping Abnormal Neurodevelopment in Schizophrenia, Acquisition of a next-generation computing cluster, Functional-anatomic exploration of cognitive control, A High Performance Research Image Repository (RIR) for the Washington University Center of High Performance Computing (CHPC), Tau, amyloid, & white matter burden interact to impact brain networks in preclinical Alzheimer's disease, Determinants of Neurodegenerative Decline in Primary Progressive Aphasia, Identification of cognitive decline and dementia: Prediction by everyday driving behaviors and physiological responses, Multi-Domain Sensory Measures as Biomarkers of Alzheimer's Disease in Preclinical and Prodromal Stages, Early Onset AD Consortium - the LEAD Study (LEADS), Morphometry Biomedical Informatics Research Network, Alzheimer's Disease Research Center, Use of the KF Modified Story Memory Technique to Improve New Learning and Memory in Individuals with Mild Cognitive Impairment, Slow wave sleep (SWS) and the effect of African ancestry on amyloid burden, a longitudinal study, 1Florida Alzheimer's Disease Research Center, DETECT-AD: Digital Evaluations and Technologies Enabling Clinical Translation for Alzheimer's Disease, Health Disparities in Alzheimer's Disease and Mild Cognitive Impairment among Mexican Americans, Nevada Exploratory Alzheimer's Disease Research Center (NVEADRC), Cleveland Alzheimer's Disease Research Center, The Alzheimer's Disease Research Center at the University of California, Irvine, Exceptional Cognitive Aging: Neuropsychologic, Anatomic and Pathologic Correlates, HIGH PERFORMANCE BIOMEDICAL IMAGING COMPUTER RESOURCES, Stanford Alzheimer's Disease Research Center, Oregon Alzheimer's Disease Center, Rush Alzheimer's Disease Core Center, DRIVING PERFORMANCE IN PRECLINICAL ALZHEIMER'S DISEASE, Language in Primary Progressive Aphasia, Upgrade for MRI Instrument for Functional Brain Imaging, PET Imaging of Synaptic Density in Alzheimers Disease, Alzheimer's Disease Research Center - Overall, Wisconsin Alzheimer's Disease Research Center, University of Kansas Alzheimer's Disease Core Centers, Alzheimer's Prevention Initiative APOE4 Trial, New Mexico Alzheimer's Disease Research Center, Alzheimer Disease Research Center, Yale Alzheimer Disease Research Center, Arizona Alzheimer's Disease Core Center, Healthy Aging and Senile Dementia, Washington University Institute of Clinical and Translational Sciences, Memory Circuitry in MCI and Early Alzheimerâs Disease Prodrome: Molecular Drivers, PET Imaging of SV2A and Other Biomarkers in Alzheimer's Disease, Boston University Alzheimer's Disease Center, Alzheimer's Disease Research Center, Vanderbilt Alzheimer's Disease Research Center, Alzheimer's Disease Core Center, Sleep Aging and Risk for Alzheimer's disease-Resubmission-1, NINDS CENTER CORE FOR BRAIN IMAGING, University of Florida - Mt. Sinai Medical Center AD Research Center, Determinants of neurodegenerative decline in the aphasic variant of Alzheimer's disease, Laboratory of Neuro Imaging Resource (LONIR), GPU COMPUTING RESOURCE TO ENABLE INNOVATION IN IMAGING AND NETWORK BIOLOGY, Modulators of Medial Temporal Lobe Subregion Structure and Function in Normal and Pathological Aging, Exceptional Cognitive Aging: Neuropsychologic, Anatomic and Pathologic Correlates, Treating mild cognitive impairment with transcranial direct current stimulation, ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration, Cycle 2 (ALLFTD2), Boston University Alzheimer's Disease Research Center, Yale Alzheimer Disease Research Center, UCSD Shiley-Marcos Alzheimer's Disease Research Center P30, Health and Aging Brain among Latino Elders (HABLE-AT(N)) Study, North Texas ADRC, Joint Estimate Diffusion Imaging (JEDI) for improved Tissue Characterization and Neural Connectivity in Aging and Alzheimer's Disease, Michigan Alzheimer's Disease Research Center, University of Kansas Alzheimer's Disease Research Center (KU ADRC), Alzheimer Disease Research Center, Alzheimer's Disease Research Center, Oregon Alzheimer's Disease Research Center, Alzheimer's Disease Research Center, Alzheimer's Disease Neuroimaging Initiative (ADNI4), Impact of Amyloid and Tau on the Aging Brain: The Harvard Aging Brain Study, UC Davis Alzheimer's Disease Research Center, Vanderbilt Alzheimer's Disease Research Center, Johns Hopkins Alzheimer's Disease Research Center, Epigenetic Risk Factors for AD Age at Onset and Health Disparities: HABLE Epigenetics Study, Indiana Alzheimer's Disease Research Center, Cleveland Alzheimers Disease Research Center, New Approaches to Dementia Heterogeneity, ASYMMETRIC NEURODEGENERATION AND LANGUAGE IN PRIMARY PROGRESSIVE APHASIA, Arizona Alzheimer's Disease Research Center, Stanford Alzheimer's Disease Research Center, Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging), APOE in the Predisposition to, Protection from and Prevention of Alzheimer's Disease, Mount Sinai Alzheimer's Disease Research Center, Mayo Alzheimer's Disease Research Center, University of Washington Alzheimer's Disease Research Center, New Mexico Alzheimer's Disease Research Center, Cognitive SuperAging: A model to explore resilience and resistance to aging and Alzheimers disease, Duke/UNC Alzheimer's Disease Research Center, Wisconsin Alzheimer's Disease Research Center, THE XNAT IMAGING INFORMATICS PLATFORM, SCAN: Standardized Centralized Alzheimer's and Related Dementias Neuroimaging, Alzheimer's Disease Research Centers, UAB Alzheimer's Disease Research Center, National Alzheimer's Coordinating Center, University of Kentucky Alzheimer's Disease Research Center, NORTHWESTERN Alzheimer's Disease Research Center, Penn Alzheimer's Disease Research Center (ADRC), The Health & Aging Brain Study - Health Disparities (HABS-HD), Advanced machine learning algorithms that integrate multi-modal neuroimaging to quantify the heterogeneity in Alzheimer's Disease, Antecedent Biomarkers for Alzheimer Disease: The Adult Children Study, Alzheimer's Disease Research Center, Massachusetts Alzheimer's Disease Research Center (MADRC), Research Program on Cognition and Neuromodulation Based Interventions (RP-CNBI), South Texas Alzheimer's Disease Center, Goizueta Alzheimer's Disease Research Center, The Alzheimer's Disease Research Center at the University of California, Irvine, The Clinical Significance of Incidental White Matter Lesions on MRI Amongst a Diverse Population with Cognitive Complaints (INDEED), Rush Alzheimer's Disease Research Center, Mayo Alzheimer's Disease Research Center
OpenAlex ID: W7147746093
Cites:
Cited by:
Related to: